Barbara Nuesslein‐Hildesheim
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Sphingolipid Metabolism and Signaling, Regulation of Appetite and Obesity, Multiple Sclerosis Research Studies, Adipose Tissue and Metabolism, NF-κB Signaling Pathways
Most-Cited Works
- → The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rate(2012)302 cited
- → Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator(2013)165 cited
- → Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase(2020)151 cited
- → Leptin selectively increases energy expenditure of food-restricted lean mice(1998)144 cited
- → The circadian cycle of mPER clock gene products in the suprachiasmatic nucleus of the Siberian hamster encodes both daily and seasonal time(2000)144 cited
- → A Monoselective Sphingosine-1-Phosphate Receptor-1 Agonist Prevents Allograft Rejection in a Stringent Rat Heart Transplantation Model(2006)126 cited
- → Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation(2015)126 cited
- → The Leptin Receptor Mediates Apparent Autocrine Regulation of Leptin Gene Expression(1997)83 cited
- → Partial Deficiency of Sphingosine-1-Phosphate Lyase Confers Protection in Experimental Autoimmune Encephalomyelitis(2013)45 cited
- → AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritis(2009)44 cited